Philip Morris International (PMI) increases its dividend by 1.6% to an annualized rate of $5.08 per share

Content of the article

NEW YORK — Regulatory news:

The board of directors of Philip Morris International Inc. (NYSE: PM) increased the company’s regular quarterly dividend by 1.6% to an annualized rate of $5.08 per share.

Content of the article

The new quarterly dividend of $1.27 per share, up from $1.25 per share, is payable on October 12, 2022 to shareholders of record on September 28, 2022. The ex-dividend date is September 27, 2022.

For details on shares, dividends and other information, click here.

Philip Morris International: Delivering a smoke-free future

Content of the article

Philip Morris International (PMI) is a leading international tobacco company striving to deliver a smoke-free future and evolving its long-term portfolio to include products outside of the tobacco and nicotine industry. The Company’s current product portfolio consists primarily of cigarettes and smokeless products, including nicotine, vapor and oral products, which are sold in markets outside of the United States. Since 2008, PMI has invested more than $9 billion to develop, scientifically substantiate, and market innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of ending the sale of cigarettes altogether. This includes developing world-class scientific evaluation capabilities, including in the areas of preclinical systems toxicology, clinical and behavioral research, and post-marketing studies. The United States Food and Drug Administration (FDA) has cleared versions of PMI for sale IQOS Platform 1 Devices and Consumables as Modified Risk Tobacco Products (MRTPs), finding that an exposure modification order for these products is appropriate to promote public health. As of June 30, 2022, excluding Russia and Ukraine, PMI’s smoke-free products are available for sale in 70 markets, and PMI estimates that approximately 13.2 million adults worldwide are already passed to IQOS and quit smoking. With a solid foundation and significant expertise in the life sciences, in February 2021, PMI announced its ambition to expand into the areas of wellness and health and provide innovative products and solutions that aim to meet unmet needs of consumers and patients. For more information, please visit and

See the source version on



Philip Morris International

Investor Relations:
New York: +1 (917) 663 2233
Lausanne: +41 (0)58 242 4666
Email: [email protected]

Lausanne: +41 (0)58 242 4500
Email: [email protected]


Comments are closed.